Philipp Arndt, Stefanie Schreiber. Reply to “CSF Amyloid‐β Risk Stratification in CAA: A Missing Link for Anti‐Amyloid Therapy Safety”. // Annals of Neurology. – 2026. – DOI: 10.1002/ana.78339. – URL: https://onlinelibrary.wiley.com/doi/10.1002/ana.78339?af=R
Philipp Arndt & Stefanie Schreiber (2026). Reply to “CSF Amyloid‐β Risk Stratification in CAA: A Missing Link for Anti‐Amyloid Therapy Safety”. Annals of Neurology. https://doi.org/10.1002/ana.78339
Philipp Arndt and Stefanie Schreiber. “Reply to “CSF Amyloid‐β Risk Stratification in CAA: A Missing Link for Anti‐Amyloid Therapy Safety”.” Annals of Neurology, 2026. doi:10.1002/ana.78339.
@article{Arndt2026,
title = {Reply to “CSF Amyloid‐β Risk Stratification in CAA: A Missing Link for Anti‐Amyloid Therapy Safety”},
author = {Arndt, Philipp and Schreiber, Stefanie},
journal = {Annals of Neurology},
year = {2026},
doi = {10.1002/ana.78339},
url = {https://onlinelibrary.wiley.com/doi/10.1002/ana.78339?af=R}
}